The pill with imprint P 10 (Pink, Round, 7mm) has been identified as Oxybutynin Chloride Extended-Release 10 mg and is used for Overactive Bladder, Dysuria, Neurogenic Detrusor …

Oxybutynin chloride extended-release tablets USP are available as 10 mg tablets for oral use: 10 mg: Pink colored, round, biconvex tablets with orifice and "P 10" imprinted with black ink.

Each DITROPAN XL Extended Release Tablet contains 5 mg, 10 mg, or 15 mg of oxybutynin chloride USP, formulated as a once-a-day controlled-release tablet for oral administration....

Oxybutynin chloride extended-release tablets, USP are available in three dosage strengths, 5 mg (pale yellow), 10 mg (pink), and 15 mg (grey) and are imprinted on one side with "EM1", …

Drug Identifier results for "Oxybutynin chloride extended release". Search by imprint, shape, color or drug name.

May 19, 2025 · The continuous release of oxybutynin from oxybutynin chloride extended-release tablets should be considered in the treatment of overdosage. Patients should be monitored for …

Oxybutynin chloride extended-release tablets USP are available as 10 mg tablets for oral use: 10 mg: Pink colored, round, biconvex tablets with orifice and "P 10" imprinted with black ink.

DITROPAN XL® extended-release tablets are available in three dosage strengths, 5 mg (pale yellow), 10 mg (pink), and 15 mg (gray) and are imprinted on one side with "5 XL", "10 XL", or...

Each oxybutynin chloride Extended-release tablets contains 5 mg, 10 mg, or 15 mg of oxybutynin chloride USP, formulated as a once-a-day controlled-release tablet for oral administration.

Oxybutynin Extended-Release Tablets What is this medication? OXYBUTYNIN (ox i BYOO ti nin) treats symptoms of an overactive bladder, such as loss of bladder control or frequent need to …